Refine
Has Fulltext
- yes (124)
Is part of the Bibliography
- yes (124)
Year of publication
- 2021 (124) (remove)
Document Type
- Doctoral Thesis (123)
- Journal article (1)
Keywords
- Melanom (3)
- Angst (2)
- Angststörung (2)
- Arteriosklerose (2)
- Chlamydia trachomatis (2)
- Chromatin (2)
- DNA repair (2)
- Entzündung (2)
- Fluoreszenzmikroskopie (2)
- Fuchsbandwurm (2)
- Furcht (2)
- Furchtkonditionierung (2)
- G-Protein gekoppelte Rezeptoren (2)
- GPCR (2)
- Genetik (2)
- HUWE1 (2)
- Induzierte pluripotente Stammzelle (2)
- MAP-Kinase (2)
- MYC (2)
- MYCN (2)
- Maus (2)
- Mausmodell (2)
- Megakaryozyt (2)
- Multiple Sklerose (2)
- Multiples Myelom (2)
- Neisseria meningitidis (2)
- Neuroblastom (2)
- Neurodegeneration (2)
- Plasmozytom (2)
- Resistenz (2)
- Serotonin (2)
- Sphingolipide (2)
- Stammzelle (2)
- Thrombozyt (2)
- Tissue Engineering (2)
- Transcription (2)
- TrkB (2)
- Ubiquitin (2)
- Zellskelett (2)
- cAMP (2)
- cell wall (2)
- host-pathogen interaction (2)
- neuroblastoma (2)
- neuropathy (2)
- regulation (2)
- 177Lu-OPS201 (1)
- 3D models (1)
- 3D tissue model (1)
- 3D-Gewebemodell (1)
- 5`-UTR (1)
- 68Ga-OPS202 (1)
- 7T (1)
- ACC (1)
- ADGRL3 (1)
- ADHD (1)
- AI (1)
- ATF5 (1)
- ATGL (1)
- Acetylation (1)
- Acute myeloid leukemia (AML) (1)
- Adhesion GPCR (1)
- Adipose (1)
- Adipose-Derived Stromal/Stem Cells (1)
- Adrenalin (1)
- Adrenokortikales Karzinom (1)
- Advanced Therapy Medicinal Products (ATMP) (1)
- Adventitia (1)
- Agarose (1)
- Aiolos (1)
- Airway epithelia (1)
- Alzheimerkrankheit (1)
- Angstverhalten (1)
- Anthropocene (1)
- Anti-CD52-Antikörper (1)
- Antibody (1)
- Antigen CD44 (1)
- Antioxidantien (1)
- Aortenaneurysma (1)
- Arbeitsteilung (1)
- Arid biomes (1)
- Arrestine (1)
- Artesunate (1)
- Arzneimittel (1)
- Arzneimitteldesign (1)
- Arzneimittelzulassung (1)
- Aspergillus fumigatus (1)
- Atherosklerose (1)
- Aufmerksamkeit (1)
- Aufmerksamkeitsdefizit-Syndrom (1)
- Aurora-A (1)
- Aussterbedynamik (1)
- Autoantikörper (1)
- B cells (1)
- BDNF (1)
- BRCA1 (1)
- BTB domain (1)
- Bacillus subtilis (1)
- Bahnung (1)
- Bakterienzellwand (1)
- Basal Ganglia (1)
- Basalganglien (1)
- Bildanalyse (1)
- Biodistribution (1)
- Biogenese (1)
- Biolayerinterferometrie (1)
- Biologie (1)
- Bioluminescence resonance energy transfer (1)
- Biomarker (1)
- Biomaterial (1)
- Bioprinting (1)
- Bioreactor (1)
- Bioreaktor (1)
- Bitopic Ligands (1)
- Bitopische Liganden (1)
- Blickbewegung (1)
- Blickinteraktion (1)
- Blut-Rückenmarkschranke (1)
- Bordetella (1)
- Brain (1)
- Brain-derived neurotrophic factor (1)
- C. elegans (1)
- CCR4 (1)
- CD28 (1)
- CD28-SA (1)
- CD44 (1)
- CD84 (1)
- CDK4 Inhibitor (1)
- CDK4 inhibitor (1)
- CIDP (1)
- CMT1A (1)
- Caenorhabditis elegans (1)
- Camponotus rufipes (1)
- Candida albicans (1)
- Cardiac (1)
- Cardiomyocyte (1)
- Cartilage (1)
- Cartilage Tissue Engineering (1)
- Cataglyphis (1)
- Ccr4-Not (1)
- Celecoxib (1)
- Cell-Assisted Lipotransfer (1)
- Ceramide (1)
- Charcot-Marie-Tooth 1A (1)
- Chemotaxis (1)
- Chimeric antigen receptor (CAR) (1)
- Chimpanzee (1)
- Chronobiologie (1)
- Ciliary neurotrophic factor (1)
- Click-Chemie (1)
- Co-Kultur (1)
- Co-culture system (1)
- Cochlear-Implantat (1)
- Comoé National Park (1)
- Complement system (1)
- Conditioning (1)
- Cortico-striatal projection neurons (1)
- Craniosynostosis (1)
- Cushing-Syndrom (1)
- Cuticular transpiration (1)
- Cuticular waxes (1)
- Cyclo-AMP (1)
- Cystein (1)
- Cytoskeleton (1)
- DC (1)
- DNS-Reparatur (1)
- DOT1 (1)
- DTI (1)
- Danio rerio (1)
- Decapping (1)
- Deeplearning (1)
- Deletion (1)
- Dendritische Zelle (1)
- Depletion (1)
- Depression (1)
- Diabetes mellitus (1)
- Differential scanning calorimetry (1)
- Diffusionsgewichtete Magnetresonanztomografie (1)
- Drosophila (1)
- Drug resistance (1)
- Duplikation (1)
- E2 (1)
- ECAP (1)
- ECG-gated PET (1)
- EEG (1)
- Early-Life Stress (1)
- Echinococcus multilocularis (1)
- Effect anticipation (1)
- Effektantizipation (1)
- Einzelmolekülmikroskopie (1)
- Elektrostimulation (1)
- Entwicklung (1)
- Eosinophiler Granulozyt (1)
- Epigenetic (1)
- Epigenetik (1)
- Evolution (1)
- Expansion microscopy (1)
- Expansionsmikroskopie (1)
- Experimentelle autoimmune Enzephalomyelitis (1)
- Exposition (1)
- Expositionslernen (1)
- Expositionstherapie (1)
- Extinktion (1)
- Extracellular Vesicles (1)
- FLT3 inhibitor (1)
- FMS-like tyrosine kinase 3 (FLT3) (1)
- FRET (1)
- FT-IR-Spektroskopie (1)
- Ferroptosis (1)
- Fertilization in angiosperm (1)
- Fibromyalgia (1)
- Fibromyalgie (1)
- Fitness (1)
- Flavonoide (1)
- Flippase (1)
- Flow (1)
- Fluconazol (1)
- Fluconazole (1)
- Fluorescence correlation spectroscopy (1)
- Fluss (1)
- Folliculin (1)
- Foxo1 (1)
- Fragmentscreening (1)
- Functional analyses (1)
- Furagieraktivität (1)
- Furchtgeneralisierung (1)
- Förster Resonanz Energie Transfer (1)
- G glycoprotein (1)
- G-Protein gekoppelter Rezeptor (1)
- G-protein-coupled receptors (1)
- GMP (1)
- Gaze interaction (1)
- Gefäßwand (1)
- Gefäßwand-residente Stamm- und Vorläuferzellen (1)
- Gehirn (1)
- Gen BRCA 1 (1)
- Genetics (1)
- Genexpression (1)
- Genotoxicity (1)
- Genotoxizität (1)
- Genregulation (1)
- Gewebekultur (1)
- Glia (1)
- Glioblastom (1)
- Gliom (1)
- Glucose Starvation (1)
- Glutathion (1)
- Glycinrezeptor (1)
- Glycophyten (1)
- Glykomodifizierung (1)
- Glykosylierung (1)
- Gonococcal invasion (1)
- GvHD (1)
- H2A.Z (1)
- HECTD1 (1)
- HFpEF (1)
- Halophyten (1)
- Halophytes (1)
- Heart (1)
- Heart development (1)
- Heat stress (1)
- Helicobacter pylori (1)
- Herz (1)
- Herzinfarkt (1)
- Heubacillus (1)
- High-thropughput screening (1)
- Hippo pathway (1)
- Hippocampus (1)
- Hirnhaut (1)
- Histon-Methyltransferase (1)
- Histonacetyltransferase (1)
- Histone (1)
- Histone Acetylation (1)
- Histone modification (1)
- Histone variant (1)
- Hochauflösungsmikroskopie (1)
- Hochdurchsatz-Screening (1)
- Hornhaut (1)
- Huh6 (1)
- Human Transcriptome (1)
- Human-pathogenic (1)
- Hyaliner Knorpel (1)
- Hyaluronsäure (1)
- Hydrogel (1)
- Hypoxia (1)
- Hypoxie (1)
- Hämophilie A (1)
- Höhenangst (1)
- IKZF1 (1)
- IKZF3 (1)
- IRAK2 (1)
- Ideomotor gaze control (1)
- Ideomotorik (1)
- Ideomotorische Blickkontrolle (1)
- Ikaros (1)
- Immunological synapse (1)
- Immunozyt (1)
- Immunsystem (1)
- Immunzellrekrutierung (1)
- In-vitro-Kultur (1)
- Individualisierte Medizin (1)
- Infektion (1)
- Inflammation (1)
- Inhibitor (1)
- Insektenstaaten (1)
- Insulin (1)
- Interleukin (1)
- Interleukin 5 (1)
- Interleukin-4 Antagonist (1)
- Intracellular bacteria (1)
- Intrazelluläre Bakterien (1)
- Ischemia (1)
- Karotis-Intima-Media-Dicke (1)
- Kleine Proteine (1)
- Kleinkern (1)
- Knorpel (1)
- Kofaktorbindung (1)
- Kognition (1)
- Kognitive Beeinträchtigung (1)
- Komplement (1)
- Konditionierung (1)
- Konnektivitätsschätzung (1)
- Kopienzahlvariation (1)
- Kraniosynostose (1)
- Krebsforschung (1)
- Kutikula (1)
- Kutikularwachs (1)
- Künstliche Intelligenz (1)
- LPS Biosynthese (1)
- Labeling (1)
- Langerhans cells (1)
- Lasiocarpin (1)
- Latrophilin (1)
- Lebendzellmikroskopie (1)
- Leber-Metabolismus (1)
- Leishmania (1)
- Lenalidomid (1)
- Lernen (1)
- Letalität (1)
- Ligand <Biochemie> (1)
- Lipid Raft (1)
- Lipid Transfer Protein (1)
- Lipide (1)
- Lipolysis (1)
- Lung (1)
- Lunge (1)
- M1 Muscarinic Receptor (1)
- MEK5/ERK5 (1)
- MGMT (1)
- MIZ1 (1)
- MS2-affinity purification and RNA-seq (1)
- Macrophages (1)
- Magnetresonanztomographie (1)
- Makrophage (1)
- Marketing authorisation of pharmaceuticals (1)
- Mauerbiene (1)
- Mechanical deformation (1)
- Mechanismus (1)
- Medium spiny neurons (1)
- Megakaryocyte (1)
- Meninges (1)
- Merkel cell carcinoma (1)
- Merkel cell polyomavirus (1)
- Mesenchymal stem cell (1)
- Mesenchymal stromal cells (1)
- Mesenchymzelle (1)
- Metabolism (1)
- Metabolismus (1)
- Methylierung (1)
- MgrB (1)
- Microglia (1)
- Micronucleus (1)
- Microvesicle (1)
- Mikroglia (1)
- Mitochondria (1)
- Mitochondrien (1)
- Mitochondrium (1)
- Mittelohrimplantat (1)
- Model Organism (1)
- Modellorganismus (1)
- Modellsystem (1)
- Modifizierung (1)
- Monozyt (1)
- Morbus Alzheimer (1)
- Motor learning (1)
- Motorisches Lernen (1)
- Mouse Model (1)
- Mucormykose (1)
- Multiproteinkomplex (1)
- Mundschleimhautzellen (1)
- Muscarinrezeptor (1)
- Mutagenität (1)
- Myb-MuvB complex (1)
- Myeloid (1)
- Myokardinfarkt (1)
- N-Myc (1)
- NK cell (1)
- NK-DC cross-talk (1)
- NRF2 (1)
- NTRK fusions (1)
- Nasenschleimhaut (1)
- Natürliche Killerzelle (1)
- Neisseria gonorrhoeae (1)
- Neuartige Arzneimittel (1)
- Neuralgie (1)
- Neuroanatomie (1)
- Neuroethologie (1)
- Neuroinflammation (1)
- Neuronales visuelles System (1)
- Neuropathie (1)
- Neuropathischer Schmerz (1)
- Neuropeptide (1)
- Neuroprotektivum (1)
- Neuroscience (1)
- Neutrophil (1)
- Neutrophil granulocyte (1)
- Neutrophiler Granulozyt (1)
- Nozizeption (1)
- Nucleotide excision repair (1)
- Nukleotid-Exzisions-Reparatur (1)
- O(6)-Methylguanine-DNA Methyltransferase (1)
- Obesity (1)
- Opiatrezeptor (1)
- Opioide (1)
- Oxidativer Stress (1)
- Oxygen partial pressure (1)
- P4-ATPase (1)
- PAF1c (1)
- PDE (1)
- PRR (1)
- PVM (1)
- Palbociclib (1)
- Parc National de la Comoé (1)
- Parkinson Krankheit (1)
- Parkinson's disease (1)
- Pathogenität (1)
- Pathophysiologie (1)
- Pathophysiologische Mechanismen (1)
- Pattern-Recognition-Receptors (1)
- Persistence (1)
- Pertussis (1)
- Pflanzenaussterben (1)
- Phasenvariation (1)
- Phenotypic switch (1)
- Phosphodiesterase (1)
- Pilzkörper (1)
- PinT (1)
- Plant cuticle (1)
- Plasmamembran (1)
- Plastizität (1)
- Pneumoviruses (1)
- Pollen (1)
- Positronen-Emissions-Tomografie (1)
- Preclinical studies (1)
- Primäre Ziliendyskinesie (1)
- Primärelement (1)
- Primärzellen (1)
- Progenitor (1)
- Protein purification (1)
- Protein-Protein-Interaktion (1)
- Protein-Protein-Wechselwirkung (1)
- Proteinkinase D (1)
- Proteinmodifizierung (1)
- Präklinische Studien (1)
- Präzisionsmedizin (1)
- Psychotherapie (1)
- Punktmutation (1)
- Pyrrolizidinalkaloide (1)
- QPCR (1)
- Qualitätsindikator (1)
- RNS-Interferenz (1)
- RSV (1)
- Receptor dynamics (1)
- Regenerative Medicine (1)
- Regulation (1)
- Regulatorischer T-Lymphozyt (1)
- Resilienz (1)
- Resistance (1)
- Respiratorisches System (1)
- Rezeptorblocker (1)
- Rezidiv (1)
- Rhizopus arrhizus (1)
- Ribonuclease H2 (1)
- Riboregulation (1)
- Risikofaktoren (1)
- Rossameise (1)
- Röntgenkristallographie (1)
- SLC2A3 (1)
- SMN (1)
- Salmonella (1)
- Salmonella Typhimurium (1)
- Scaffold bone implant (1)
- Schimpanse (1)
- Schizosaccharomyces pombe (1)
- Schlaganfall (1)
- Schließzellfunktion (1)
- Secretion (1)
- Sekundäre Inflammation (1)
- Selective extraction (1)
- Senecionin (1)
- Seneciphyllin (1)
- Sequenzwiederholung (1)
- Serotonindefizienz (1)
- Signaltransduktion (1)
- Sleeping Beauty Transposon System (1)
- Small RNA (1)
- Small angle X-ray scattering (1)
- Social action effects (1)
- Sociomotor gaze control (1)
- Soziale Handlungseffekte (1)
- Soziomotorische Blickkontrolle (1)
- SteC (1)
- Sterblichkeit (1)
- Stiff-Person Syndrom (1)
- Stiff-person syndrome (1)
- Stress (1)
- Striatum (1)
- Strukturbiologie (1)
- Superresolution microscopy (1)
- Survival Motor Neuron (1)
- Synaptic plasticity (1)
- Synchronitätsmessung (1)
- T cell engaging Antibody (1)
- TFIIH (1)
- TH2 Immunantwort (1)
- TLR signaling (1)
- Telomerase (1)
- Thebain (1)
- Therapie (1)
- Therapieresistenz (1)
- Thrombopoiesis (1)
- Tight junction (1)
- Tissue engineering (1)
- Toll-like-Rezeptoren (1)
- TraDIS (1)
- Transkription (1)
- Transkriptionsfaktor (1)
- Transkriptomanalyse (1)
- Transkriptomik anlyze (1)
- Transpiration <Pflanzen> (1)
- Transposon (1)
- Treg (1)
- Trend (1)
- Trophic Factors (1)
- Trypanosoma Brucei (1)
- Trypanosoma brucei (1)
- UBE2S (1)
- Ubiquitin-PA (1)
- Ubiquitin-Protein-Ligase (1)
- Ubiquitin-conjugating enzyme (1)
- Ubiquitinierung (1)
- VW-SCs (1)
- Validierung (1)
- Verhalten (1)
- Verhaltenskontrolle (1)
- Very-long-chain aliphatic (1)
- Vesikelbildung (1)
- Vessel wall (1)
- Virtuelle Realität (1)
- Visuelle Aufmerksamkeit (1)
- Vorläufer (1)
- Water stress (1)
- Wirkstoffdesign (1)
- X-ray crystallography (1)
- X-ray diffraction (1)
- Yeast (1)
- Zellzyklus (1)
- Zink-Finger-Proteine (1)
- aGPCR (1)
- acute graft-versus host disease (1)
- adhesion-GPCR (1)
- adrenal gland (1)
- adrenergic receptor (1)
- adrenocortical carcinoma (1)
- airways (1)
- allogeneic stem cell transplantation (1)
- alloreactive T cells (1)
- antimicrobial (1)
- anxiety disorders (1)
- articular cartilage progenitor cells (1)
- atopic diseases (1)
- attributable fraction (1)
- attributable risk (1)
- autoantibody (1)
- autophagocytose (1)
- autophagy (1)
- bacterial lipid rafts (1)
- behavior (1)
- beta-Arrestin2 (1)
- bicuculline (1)
- binding mode (1)
- biochemistry (1)
- biodistribution (1)
- bioimage analysis (1)
- biokinetics (1)
- biolayerinterferometry (1)
- bioreactor (1)
- blood nerve barrier (1)
- bone marrow (1)
- bumblebee*s (1)
- cancer (1)
- candida (1)
- candida albicans (1)
- cartilage (1)
- chlamydia (1)
- chondrogene Differenzierung (1)
- circadian rhythms (1)
- claudin-12 (1)
- co-culture (1)
- cochlea implant (1)
- cofactorbinding (1)
- compartments (1)
- corneal confocal microscopy (1)
- correlation (1)
- cushing's syndrome (1)
- cytokine release syndrome (1)
- cytoskeleton (1)
- dCIRL (1)
- dSTORM (1)
- developmental differentiation (1)
- diabetic cardiomyopathy (1)
- diagnostics (1)
- diastolic dysfunction (1)
- diet (1)
- disease model (1)
- distance (1)
- distribution (1)
- double-strand break repair (1)
- drug repurposing (1)
- dual RNA-seq (1)
- ecology (1)
- effector protein (1)
- electron microscopy (1)
- eosinophil (1)
- evozierte Potentiale (1)
- exposition training (1)
- expression (1)
- extinction dynamics (1)
- fabry disease (1)
- fear conditioning (1)
- fibromyalgia sydrome (1)
- foraging activity (1)
- foxtapeworm (1)
- fragment screening (1)
- functional membrane microdomains (1)
- functional studies (1)
- fungus (1)
- genotoxicity (1)
- germinative cell (1)
- gezielte Therapie (1)
- glycine receptor autoantibodies (1)
- glycophytes (1)
- guard cells (1)
- habitat (1)
- hematopoiesis (1)
- hippocampus (1)
- homoFRET (1)
- honeybee (1)
- honeybee*s (1)
- huh6 (1)
- iPSC (1)
- in vitro Kulturmodelle (1)
- in vitro Testsystem (1)
- interleukin-5 signaling (1)
- internal dosimetry (1)
- interphase gap (1)
- interpulse interval (1)
- intraoperative Ankopplungseffizienz (1)
- kinase (1)
- labeling techniques (1)
- lasiocarpine (1)
- learning (1)
- lipid rafts (1)
- lymph node stromal cells (1)
- lymph node transplantation (1)
- mechanistische Modellierung (1)
- melanoma dedifferentiation (1)
- membrane dynamics (1)
- mesenteric lymph node (1)
- metabolic theory of ecology (1)
- microelectrode array (1)
- mouse models (1)
- mucormycosis (1)
- myelin barrier (1)
- neuroethology (1)
- neuromodulation (1)
- neuronal visual system (1)
- neuropeptides (1)
- neutrophil (1)
- nociception (1)
- nutrients (1)
- nutrition (1)
- p97 (1)
- pain (1)
- pathophysiological mechanisms (1)
- peptide (1)
- peptide engineering (1)
- peptide-based interleukin-5 inhibitor (1)
- perception (1)
- phosphorylation (1)
- platelets (1)
- polarized epithelium (1)
- pollen (1)
- polyethism (1)
- polyradiculoneuropathy (1)
- population attributable fraction (1)
- precision medicine (1)
- preclinical PET (1)
- primary ciliary dyskinesia (1)
- primate (1)
- proboscis extension response (1)
- protease (1)
- protein kinase a (1)
- protein regulation and expression (1)
- protein-protein-interaction (1)
- psychosocial resilience (1)
- rapid evolution (1)
- reception (1)
- receptor (1)
- replication (1)
- resilience (1)
- salinen Wachstumsbedingungen (1)
- salt stress (1)
- schnelle Evolution (1)
- self-activation (1)
- senecionine (1)
- seneciphylline (1)
- shRNA (1)
- signalling (1)
- similarity (1)
- skin (1)
- skin biopsy (1)
- small RNA (1)
- small fiber pathology (1)
- small proteins (1)
- somatic resilience (1)
- somatostatin receptor antagonists (1)
- sphingolipids (1)
- ssVEP (1)
- stiff person syndrome (1)
- structural mechanism (1)
- structure analysis (1)
- super-resolution microscopy (1)
- synaptic plasticity (1)
- synaptische Plastizität (1)
- targeted therapy (1)
- tdcs (1)
- temporal information transfer (1)
- test system (1)
- therapy (1)
- time-resolved anisotropy (1)
- tool (1)
- tool-use (1)
- tracheal cytotoxin (1)
- trachomatis (1)
- transcription/replication conflicts (1)
- transcriptome data analysis (1)
- transcriptomic analysis (1)
- transient dynamics (1)
- tumour (1)
- tyrosine kinase (1)
- virulence (1)
- yeast (1)
- zeitlich Informationsübertragung (1)
- zonal Hydrogels (1)
- µ-Opioid Rezeptor (1)
- Ängstliche Depression (1)
Institute
- Graduate School of Life Sciences (124) (remove)
Sonstige beteiligte Institutionen
- Biomedical Center Munich, Department of Physiological Chemistry, Ludwig-Maximilians-Universität München (1)
- Department of Veterinary Sciences, Experimental Parasitology, Ludwig-Maximilians-Universität München (1)
- Max-Delbrück-Center für molekulare Medizin, Berlin (1)
- Research Center for Infectious Diseases, University of Würzburg (1)
- Spanish National Center for Biotechnology (CNB-CSIC) (1)
- Technische Universität Darmstadt (1)
- University of Applied Sciences Aschaffenburg (1)
- University of Leipzig, Faculty of Life Sciences, Institute for Biology (1)
- Zentrum für Infektionsforschung (ZINF) Würzburg (1)
Hormones are essential components in the body and their imbalance leads to pathological consequences. T2DM, insulin resistance and obesity are the most commonly occurring lifestyle diseases in the past decade. Also, an increased cancer incidence has been strongly associated with obese and T2DM patients.
Therefore, our aim was to study the influence of high insulin levels in accumulating DNA damage in in vitro models and patients, through the induction of oxidative stress. The primary goal of this study was to analyze the genotoxicity induced by the combined action of two endogenous hormones (insulin and adrenaline) with in vitro models, through the induction of micronuclei and to see if they cause an additive increase in genomic damage. This is important for multifactorial diseases having high levels of more than one hormone, such as metabolic syndrome and conditions with multiple pathologies (e.g., T2DM along with high stress levels).
Furthermore, the combination of insulin and the pharmacological inhibition of the tumor suppressor gene: PTEN, was to be tested in in vitro models for their genotoxic effect and oxidative stress inducing potential. As the tumor suppressor gene: PTEN is downregulated in PTEN associated syndromes and when presented along with T2DM and insulin resistance, this may increase the potential to accumulate genomic damage.
The consequences of insulin action were to be further elucidated by following GFP-expressing cells in live cell-imaging to observe the ability of insulin, to induce micronuclei and replicative stress. Finally, the detrimental potential of high insulin levels in obese patients with hyperinsulinemia and pre-diabetes was to be studied by analyzing markers of oxidative stress and genomic damage. In summary, the intention of this work was to understand the effects of high insulin levels in in vitro and in patients to understand its relevance for the development of genomic instability and thus an elevated cancer risk.
Identification of new drug targets in adrenocortical carcinoma through targeted mRNA analysis
(2021)
Adrenocortical carcinomas (ACC) are aggressive tumors associated with a heterogeneous but generally poor prognosis and limited treatment options for advanced stages. Despite promising molecular insights and improved understanding of ACC biology, efficient targeted therapies have not been identified yet. Thus, this study aims to identify potential new drug targets for a future personalized therapeutic approach.
RNA was isolated from 104 formalin-fixed paraffin-embedded tumor samples from ACC patients, 40 of those 104 cases proved to be suitable for further mRNA analyses according to the quality check of the extracted RNA. Gene expression of 84 known cancer drug targets was evaluated by quantitative real-time PCR using 5 normal adrenal glands as reference. Protein expression was investigated for selected candidate drug targets by immunohistochemistry in 104 ACC samples, 11 adenomas and 6 normal adrenal glands. Efficacy of an available inhibitor of the most promising candidate was tested by functional in vitro experiments in two ACC cell lines (NCI-H295R and MUC1) alone or in combination with other drugs.
Most frequently overexpressed genes were TOP2A, IGF2, CDK1, CDK4, PLK4 and PLK1. Nuclear immunostaining of CDK1, CDK4 and PLK1 significantly correlated with the respective mRNA expression. CDK4 was chosen as the most promising candidate for functional validation as it is actionable by FDA-approved CDK4/6 inhibitors. ACC samples with copy number gains at CDK4 locus presented significantly higher CDK4 expression levels. The CDK4/6 inhibitor palbociclib showed a concentration- and time- dependent reduction of cell viability in vitro, which was more pronounced in NCI-H295R than in MUC1 cells. This was in line with higher CDK4 expression at western blot analysis in NCI-H295R cells. Furthermore, palbociclib was applied in combination with dual IGFR/IR inhibitor linsitinib showing a synergistic effect on reducing cell viability. In conclusion, this proof-of-principle study confirmed RNA profiling to be useful to discover potential drug targets. Detected drug targets are suitable to be investigated by immunohistochemistry in the clinical setting. Moreover, CDK4/6 inhibitors are promising candidates for treatment of a subset of patients with tumors presenting CDK4 copy number gains and/or overexpression, while linsitinib might be an interesting combination partner in patients with both IGF2 and IGF1R overexpression.
These results are intended as a basis for a validation study in a prospective cohort, further evaluation in vivo in suitable mouse models or testing in patients with ACC in clinical trials are needed and might improve the future management of patients with ACC in terms of precision medicine.
Hematopoietic cell transplantation (HCT) is a curative therapy for the treatment of malignant and non-malignant bone marrow diseases. The major complication of this treatment is a highly inflammatory reaction called Graft-versus-Host Disease (GvHD). Here, transplanted donor T cells cause massive tissue destruction and inflammation in the main target organs liver, skin and the intestine. Currently, this inflammatory reaction can be treated successfully using strong immunosuppressive agents. One efficient group of immunosuppressants are calcineurin inhibitors such as Cyclosporin A (CsA) and Tacrolimus (FK506). These treatment strategies target all T lymphocytes subsets equally and do not separate GvH from the desirable Graft-versus-Leukemia (GvL) effect. Therefore, we aimed to find immunological targets on alloreactive T cells in order to develop novel treatment strategies, which selectively modulates alloreactive T cells without impairing the GvL effect or hematopoietic immune reconstitution.
The aim of this thesis was to develop a predictive marker panel to track alloreactive T cells in the peripheral blood (PB) of murine allo-HCT recipients. In clinically relevant model of aGvHD we demonstrated that alloreactive T cells have a distinct surface marker expression profile and can be detected in the PB before aGvHD manifestation. Based on our data, we propose a combinatory panel consisting of 4 surface markers (a4b7 integrin, CD162E, CD162P und CD62L) on circulating CD8+ T cells to identify the risk of aGvHD after allo-HCT.
Since tumor necrosis factor receptor superfamily (TNFR SF) members are involved in several immunological processes, we did extensive surface marker expression analysis of several TNFR superfamily members and other immunomodulatory molecules on conventional and regulatory T cells (Tcons vs. Tregs) on different time points during aGvHD progression. The aim of this study was to find subset-specific immunomodulatory molecules on recently activated Tcons and Tregs. We found that GITR, 4-1BB and CD27 were highly expressed on alloreactive and naïve Tregs. In contrast, PD1 expression was highly upregulated on recently activated alloreactive Tcons. The data of this study serves as basis for future approaches, which aim to develop T cell subset specific therapeutic antibody fusion proteins.
a4b7 integrin and CD162P (P-Selectin ligand) are highly upregulated on alloreactive T cells and mediate the infiltration of these cells into GvHD target organs. We developed recombinant (antibody) fusion proteins to target these two homing molecules and could show that antibody-based fusion proteins are superior to ligand-based fusion proteins regarding production efficiency and binding affinity. Therefore, we propose for future studies to focus on the described antibody-based fusion proteins for the selective targeting of T cells.
Since the widely used calcineurin inhibitors are impairing the desirable GvL effect, we investigated if selective NFATc1 inhibition might be a novel strategy to prevent or reduce alloreactivity, while hopefully maintaining the GvL effect. In particular, we addressed the role of the isoform NFATc1 and inhibited its posttranslational modification by SUMO (Small Ubiquitin-related Modifier). Indeed, inhibition of NFATc1 SUMOylation resulted in reduced inflammation and increased Treg frequencies in a murine MHC major mismatch aGvHD model.
Conclusively, we showed that alloreactive T cells can be identified by their surface profile in the PB of allo-HCT recipients before aGvHD symptoms appeared. Furthermore, we introduced a approach to selectively target alloreactive T cells by antibody fusion proteins, which might serve as a novel strategy to separate GvH from GvL. Additionally, we demonstrated that averted posttranslational modification of NFATc1 by SUMOylation serves as potential target to reduce alloreactivity of T cells.
Small proteins, often defined as shorter than 50 amino acids, have been implicated
in fundamental cellular processes. Despite this, they have been largely understudied throughout all domains of life, since their size often makes their identification and characterization challenging.
This work addressed the knowledge gap surrounding small proteins with a focus
on the model bacterial pathogen Salmonella Typhimurium. In a first step,
new small proteins were identified with a combination of computational and experimental approaches. Infection-relevant datasets were then investigated with
the updated Salmonella annotation to prioritize promising candidates involved in virulence.
To implement the annotation of new small proteins, predictions from the algorithm
sPepFinder were merged with those derived from Ribo-seq. These were added to the Salmonella annotation and used to (re)analyse different datasets. Information
regarding expression during infection (dual RNA-seq) and requirement for virulence (TraDIS) was collected for each given coding sequence. In parallel,
Grad-seq data were mined to identify small proteins engaged in intermolecular
interactions.
The combination of dual RNA-seq and TraDIS lead to the identification of small
proteins with features of virulence factors, namely high intracellular induction
and a virulence phenotype upon transposon insertion. As a proof of principle of
the power of this approach in highlighting high confidence candidates, two small
proteins were characterized in the context of Salmonella infection.
MgrB, a known regulator of the PhoPQ two-component system, was shown to be essential for the infection of epithelial cells and macrophages, possibly via its stabilizing effect on flagella or by interacting with other sensor kinases of twocomponent
systems. YjiS, so far uncharacterized in Salmonella, had an opposite role in infection, with its deletion rendering Salmonella hypervirulent. The mechanism underlying this, though still obscure, likely relies on the interaction with
inner-membrane proteins.
Overall, this work provides a global description of Salmonella small proteins in
the context of infection with a combinatorial approach that expedites the identification
of interesting candidates. Different high-throughput datasets available for
a broad range of organisms can be analysed in a similar manner with a focus on small proteins. This will lead to the identification of key factors in the regulation
of various processes, thus for example providing targets for the treatment of bacterial
infections or, in the case of commensal bacteria, for the modulation of the microbiota composition.